We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
Consensus vs. actual, and revenue trend
| 분기 | 발표일 | 시각 | EPS 예상 | EPS 실제 | 서프라이즈 | 매출 예상 | 매출 실제 | 상태 |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 30. | 장 마감 후 (AMC) | $0.44 | — | — | $20.35M | — | 예정 |
| FY2026 Q1 | 2025. 03. 31. | 시각 미정 | — | $0.37 | — | — | $19.51M | 보고됨 |
| FY2025 Q3 | 2024. 09. 30. | 시각 미정 | — | $1.1 | — | — | $53.85M |
Consensus PT $118 · 2 analysts
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2026. 04. 02. | Freedom Broker | — | 커버리지 개시 | — → Buy | — | Freedom Broker: Buy |
| 2025. 02. 15. | Roth MKM | — | 의견 유지 | Buy → Buy | — | Roth MKM: Buy |
동일 리서치펌의 과거 의견 변화, 동일 섹터 내 다른 종목 액션과 비교 가능
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
| FY2025 Q2 | 2024. 06. 30. | 시각 미정 | — | $0.71 | — | — | $35.53M | 보고됨 |
Automated summary from public sources · not investment advice
공시·실적·기관 변화를 한국어 한 단락으로 요약. 원문 출처와 함께 제공됩니다.
Ranked by position value
| # | 기관 | 운용 형태 | 보유 주식 | 평가액 | 비중 | 변화율 | 포지션 |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 165,669 | $15.95B | 0.01% | — | 신규 편입 |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 64,914 | $6.31B | 0.01% | — | 신규 편입 |
신규 편입·전량 매도·비중 변화까지 모두 확인할 수 있습니다.
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
Stored first · Google News · Yahoo Finance (English)
Iradimed Corp Quarterly Report Highlights Key Growth Drivers - Earnings Call Q&A - thelegaladvocate.com
Iradimed Corp Quarterly Report Highlights Key Growth Drivers - Earnings Call Q&A thelegaladvocate.com
Iradimed Reports 13 Percent Revenue Growth in First Quarter of 2026 - HarianBasis.co
Iradimed Reports 13 Percent Revenue Growth in First Quarter of 2026 HarianBasis.co
Iradimed Insider Sold Shares Worth $691,044, According to a Recent SEC Filing - Moomoo
Iradimed Insider Sold Shares Worth $691,044, According to a Recent SEC Filing Moomoo
Iradimed Insider Sold Shares Worth $691,044, According to a Recent SEC Filing - marketscreener.com
Iradimed Insider Sold Shares Worth $691,044, According to a Recent SEC Filing marketscreener.com
Iradimed Insider Sold Shares Worth $691,044, According to a Recent SEC Filing
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares in 10b5-1 plan - Stock Titan
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares in 10b5-1 plan Stock Titan